(Q44991597)

English

Tecemotide (L-BLP25) versus placebo after chemoradiotherapy for stage III non-small-cell lung cancer (START): a randomised, double-blind, phase 3 trial

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

8 December 2017

Tecemotide (L-BLP25) versus placebo after chemoradiotherapy for stage III non-small-cell lung cancer (START): a randomised, double-blind, phase 3 trial (English)

1 reference

Europe PubMed Central

8 December 2017

chemoradiotherapy

0 references

phase III clinical trial

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

14

object named as

Rodryg Ramlau

1 reference

Europe PubMed Central

8 December 2017

Sergiusz Nawrocki

object named as

Sergiusz Nawrocki

7

0 references

Maciej Krzakowski

object named as

Maciej Krzakowski

6

0 references

author name string

Charles Butts

1

1 reference

Europe PubMed Central

8 December 2017

Mark A Socinski

2

1 reference

Europe PubMed Central

8 December 2017

Paul L Mitchell

3

1 reference

Europe PubMed Central

8 December 2017

Nick Thatcher

4

1 reference

Europe PubMed Central

8 December 2017

Libor Havel

5

1 reference

Europe PubMed Central

8 December 2017

Tudor-Eliade Ciuleanu

8

1 reference

Europe PubMed Central

8 December 2017

Lionel Bosquée

9

1 reference

Europe PubMed Central

8 December 2017

José Manuel Trigo

10

1 reference

Europe PubMed Central

8 December 2017

Alexander Spira

11

1 reference

Europe PubMed Central

8 December 2017

Lise Tremblay

12

1 reference

Europe PubMed Central

8 December 2017

Jan Nyman

13

1 reference

Europe PubMed Central

8 December 2017

Gun Wickart-Johansson

15

1 reference

Europe PubMed Central

8 December 2017

Peter Ellis

16

1 reference

Europe PubMed Central

8 December 2017

Oleg Gladkov

17

1 reference

Europe PubMed Central

8 December 2017

José Rodrigues Pereira

18

1 reference

Europe PubMed Central

8 December 2017

Wilfried Ernst Erich Eberhardt

19

1 reference

Europe PubMed Central

8 December 2017

Christoph Helwig

20

1 reference

Europe PubMed Central

8 December 2017

Andreas Schröder

21

1 reference

Europe PubMed Central

8 December 2017

Frances A Shepherd

22

1 reference

Europe PubMed Central

8 December 2017

START trial team

23

1 reference

Europe PubMed Central

8 December 2017

publication date

9 December 2013

1 reference

Europe PubMed Central

8 December 2017

Lancet Oncology Commission

1 reference

Europe PubMed Central

8 December 2017

15

1 reference

Europe PubMed Central

8 December 2017

1

1 reference

Europe PubMed Central

8 December 2017

59-68

1 reference

Europe PubMed Central

8 December 2017

Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970510-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Early stage and locally advanced (non-metastatic) non-small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970510-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Meta-analysis of concomitant versus sequential radiochemotherapy in locally advanced non-small-cell lung cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970510-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Membrane-bound mucins: the mechanistic basis for alterations in the growth and survival of cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970510-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Dependence on the MUC1-C oncoprotein in non-small cell lung cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970510-2

7 January 2021

based on heuristic

inferred from DOI database lookup

MUC1 mediates transendothelial migration in vitro by ligating endothelial cell ICAM-1.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970510-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Human MUC1 carcinoma antigen regulates intracellular oxidant levels and the apoptotic response to oxidative stress

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970510-2

7 January 2021

based on heuristic

inferred from DOI database lookup

MUC1 oncoprotein activates the FOXO3a transcription factor in a survival response to oxidative stress

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970510-2

7 January 2021

based on heuristic

inferred from DOI database lookup

MUC1 as a target antigen for cancer immunotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970510-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Mucins in cancer: protection and control of the cell surface

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970510-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Antitumor effects of L-BLP25 antigen-specific tumor immunotherapy in a novel human MUC1 transgenic lung cancer mouse model

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970510-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized phase IIB trial of BLP25 liposome vaccine in stage IIIB and IV non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970510-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Updated survival analysis in patients with stage IIIB or IV non-small-cell lung cancer receiving BLP25 liposome vaccine (L-BLP25): phase IIB randomized, multicenter, open-label trial

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970510-2

7 January 2021

based on heuristic

inferred from DOI database lookup

A multicenter open-label study to assess the safety of a new formulation of BLP25 liposome vaccine in patients with unresectable stage III non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970510-2

7 January 2021

based on heuristic

inferred from DOI database lookup

The prioritization of cancer antigens: a national cancer institute pilot project for the acceleration of translational research

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970510-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Enhancing the effect of THERATOPE STn-KLH cancer vaccine in patients with metastatic breast cancer by pretreatment with low-dose intravenous cyclophosphamide

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970510-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Quality of life assessment in individuals with lung cancer: testing the Lung Cancer Symptom Scale (LCSS).

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970510-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase III study of cisplatin, etoposide, and concurrent chest radiation with or without consolidation docetaxel in patients with inoperable stage III non-small-cell lung cancer: the Hoosier Oncology Group and U.S. Oncology

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970510-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Updated survival and outcomes for older adults with inoperable stage III non-small-cell lung cancer treated with cisplatin, etoposide, and concurrent chest radiation with or without consolidation docetaxel: analysis of a phase III trial from the Hoo

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970510-2

7 January 2021

based on heuristic

inferred from DOI database lookup

A randomized phase III trial of combined paclitaxel, carboplatin, and radiation therapy followed by weekly paclitaxel or observation for patients with locally advanced inoperable non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970510-2

7 January 2021

based on heuristic

inferred from DOI database lookup

INSPIRE: A phase III study of the BLP25 liposome vaccine (L-BLP25) in Asian patients with unresectable stage III non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970510-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase III trial of maintenance gefitinib or placebo after concurrent chemoradiotherapy and docetaxel consolidation in inoperable stage III non-small-cell lung cancer: SWOG S0023.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970510-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Combination chemotherapy and radiation of human squamous cell carcinoma of the head and neck augments CTL-mediated lysis.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970510-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Leveraging the immune system during chemotherapy: moving calreticulin to the cell surface converts apoptotic death from "silent" to immunogenic

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970510-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Immunogenic tumor cell death for optimal anticancer therapy: the calreticulin exposure pathway

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970510-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Combining radiotherapy and cancer immunotherapy: a paradigm shift

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970510-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S1470-2045(13)70510-2

1 reference

Europe PubMed Central

8 December 2017

1 reference

Europe PubMed Central

8 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44991597&oldid=2060696645"